Xuemei Tang, MD

University at Buffalo
Buffalo, New York, United States

Disclosure information not submitted.

Presentation(s):

• 394 - Safety and Effectiveness of Long-Acting Cabotegravir/Rilpivirine in People with HIV and Severe Renal Impairment (CAPRI Trial)

  Tuesday, October 21, 2025
  2:33 PM - 2:45 PM US ET